Evidence map›Paper›PMID 37252801›Full record

ArticleImmunoHorizons2023

Negative Data, Oh No What Should I Do? How Publication of Negative Data Removes Roadblocks to Productive Research from the Perspective of Scientists Who Perform the Experiments.

Angela K Beltrame, Johnathon J Caldon, Cody J Gurski, Zivar Hajiyeva, Nathan J Meinhardt, Kelli C Sommers, Savannah D Neu, Bonnie N Dittel

Abstract readEditorial
In one paragraph

Article in ImmunoHorizons, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Angela K BeltrameVersiti Blood Research Institute, Milwaukee, WI.
Johnathon J CaldonVersiti Blood Research Institute, Milwaukee, WI.ORCID 0000-0001-5746-3709
Cody J GurskiVersiti Blood Research Institute, Milwaukee, WI.ORCID 0000-0001-7592-6367
Zivar HajiyevaVersiti Blood Research Institute, Milwaukee, WI.
Nathan J MeinhardtVersiti Blood Research Institute, Milwaukee, WI.
Kelli C SommersVersiti Blood Research Institute, Milwaukee, WI.ORCID 0000-0002-3906-4891
Savannah D NeuVersiti Blood Research Institute, Milwaukee, WI.
Bonnie N DittelVersiti Blood Research Institute, Milwaukee, WI.

Funding

Medical Scientist Training ProgramT32GM080202 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI BARBIERI, JOSEPH T, SALZMAN, NITA H · 2010 to 2024
$5.7M
Development of a B Cell TherapeuticR01AI160244 · NIAID · VERSITI WISCONSIN, INC. · PI DITTEL, BONNIE N · 2020 to 2024
$3.4M
NIAID NIH HHS R01 AI160244NIGMS NIH HHS T32 GM080202
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37252801
PMCPMC10414161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.